These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6665414)

  • 1. [Anti-HAV-specific immunoglobulins].
    Maniez-Montreuil M; Dupressoir-Burlet MV; Goudemand M
    Rev Fr Transfus Immunohematol; 1983 Nov; 26(5):531-8. PubMed ID: 6665414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to hepatitis A virus in immune serum globulin.
    Smallwood LA; Tabor E; Finlayson JS; Gerety RJ
    J Med Virol; 1981; 7(1):21-7. PubMed ID: 7241098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the content of hepatitis A antibodies in immunoglobulin preparations on the effectiveness of the immunoglobulin prophylaxis of hepatitis A].
    Gorbunov MA; Sumarokov AA; Iaroshevskaia IIu; Ikoev VN; Khalitova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):86-9. PubMed ID: 6087581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBsAG-negative blood donors with a history of jaundice as a source of plasma for preparation of hyperimmune hepatitis type A globulin.
    Hopkins R
    J Infect; 1981 Jun; 3(2):166-71. PubMed ID: 7185957
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody to hepatitis A virus in plasma of Danish blood donors and in immune serum globulin produced in Denmark.
    Mathiesen LR; Skinhøj P; Balstrup F
    Scand J Infect Dis; 1980; 12(2):81-3. PubMed ID: 6246571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tourist hepatitis, antibodies to hepatitis A virus and immune serum globulin prophylaxis.
    Iwarson S; Frösner G; Norkrans G
    Infection; 1978; 6(6):257-8. PubMed ID: 215556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of hepatitis A in Dutch hemophilia patients.
    Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; van den Berg HM; Roosendaal G; Lelie PN
    Thromb Haemost; 1995 Aug; 74(2):616-8. PubMed ID: 8584994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host immune response to hepatitis A virus.
    Stapleton JT
    J Infect Dis; 1995 Mar; 171 Suppl 1():S9-14. PubMed ID: 7876654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive immunization against hepatitis A.
    Stapleton JT
    Vaccine; 1992; 10 Suppl 1():S45-7. PubMed ID: 1335658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
    Chlibek R; Smetana J; Bostíková V; Splino M
    Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
    Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
    J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative evaluation of the content of antibodies to hepatitis of A virus in serial immunoglobulin preparations].
    Savinskaia SS; Balaian MS
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Sep; (9):72-4. PubMed ID: 6293225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis A viral RNA and antibodies among Chinese blood donors.
    Sun P; Su N; Lin FZ; Ma L; Wang HJ; Rong X; Dai YD; Li J; Jian ZW; Tang LH; Xiao W; Li CQ
    Genet Mol Res; 2015 Dec; 14(4):16431-7. PubMed ID: 26662440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
    Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W
    Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline of maternal hepatitis A virus antibody levels in infants.
    De Silvestri A; Avanzini MA; Terulla V; Zucca S; Polatti F; Belloni C
    Acta Paediatr; 2002; 91(8):882-4. PubMed ID: 12222709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.